Abbott`s FreeStyle® Libre 3 System Receives CE Mark - Features World`s Smallest, Thinnest Sensor with Best-in-Class Performance at the Same Low Cost for People with Diabetes
(WorldNews France)

ABBOTT PARK, Ill., Sept. 28, 2020/PRNewswire/ -- Abbott (NYSE: ABT), the worldwide leader in continuous glucose monitoring (CGM) technology,8 announced today it has secured CE Mark (Conformit&eaigu; Europ&eaigu;enne) for its next-generation FreeStyle Libre 3 system, which is now approved for use by people living with diabetes in Europe. The FreeStyle Libre 3 technology provides continuous, real-time glucose readings automatically delivered to smartphones2 every minute, offering unsurpassed 14-day accuracy1 in the smallest and thinnest3 sensor design at the same affordable price7 as previous versions of the device. `Abbott won`t stop innovating when there`s room to raise the bar. We`ve done that again...